Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 599-604, July 2008

In vitro and in vivo evaluation of direct rhenium-188-labeled anti-CD52 monoclonal antibody alemtuzumab for radioimmunotherapy of B-cell chronic lymphocytic leukemia

  • Mario De Decker

      Affiliations

    • Department of Radiopharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium
    • Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, Netherlands
    • Corresponding Author InformationCorresponding author. Department of Radiopharmacy, University Ghent, 9000 Ghent, Belgium. Tel.: +32 09 332 30 28; fax: +32 09 332 38 07.
    • ,
  • Klaus Bacher

      Affiliations

    • Department of Medical Physics and Radiation Protection, Ghent University, Ghent, Belgium
    • ,
  • Hubert Thierens

      Affiliations

    • Department of Medical Physics and Radiation Protection, Ghent University, Ghent, Belgium
    • ,
  • Guido Slegers

      Affiliations

    • Department of Medical Imaging of Domestic Animals, Ghent University, Ghent, Belgium
    • ,
  • Rudi A. Dierckx

      Affiliations

    • Department of Nuclear Medicine and Molecular Imaging, University Medical Centre Groningen, Groningen, Netherlands
    • ,
  • Filip De Vos

      Affiliations

    • Department of Radiopharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium

Received 5 October 2007; received in revised form 26 February 2008; accepted 4 March 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(08)00073-5

doi:10.1016/j.nucmedbio.2008.03.001

Nuclear Medicine and Biology
Volume 35, Issue 5 , Pages 599-604, July 2008

Article Tools

* Image Usage & Resolution